Most CGT operations functions were built to handle one or two modalities at a single scale. Today they're managing multi-site complexity, evolving therapy types, and commercial timelines that don't forgive slow coordination. The fractures are showing.

Free: CGT Digital Orchestration Maturity Assessment

Register and get a personalised 10-page report with maturity radar, gap analysis, and a 30-day action plan. See how your organisation stacks up before the session, and benchmark live against peers on the day.

On June 11, senior experts from Genentech/Roche, Bristol-Myers Squibb, and Hackensack University Medical Center join Phacilitate and BlueSquared for a candid conversation about where CGT programs actually break down, and what commercially ready organisations are doing differently.

From chain-of-identity and chain-of-custody pressures to fragmented digital infrastructure and governance gaps, this session will explore the operational realities emerging as advanced therapies move beyond the industry’s first-wave operating models.

→ Andy Case, Former Senior Director Supply Chain Technology, Novartis (involved in the launch and operationalisation of one of the world's first commercial CAR-T therapies)

→ Arthur Mallian, Former Executive Director IT, Head of Cell Therapy Digital Platform, BMS (helped scale operational frameworks during the industry's first wave of commercialisation)

→ Ronit Slotky PhD, MSc, CABP, Director, Cell Therapies Manufacturing Facility, Hackensack University Medical Center

→ Moderator: Becky Johnson, Global Event Director, Phacilitate

A clearer understanding of where coordination failures actually happen across CGT programs

Insight into why orchestration is becoming a distinct operational discipline in advanced therapies

Practical perspectives from experts managing complexity across sites, modalities, and stakeholder groups

Direct insight from operators who built the first generation of commercial CAR-T systems, and what they would do differently today

A live view of how the audience scores across key operational maturity domains

Access to BlueSquared's CGT Digital Orchestration Maturity Assessment, including a personalised 10-page report with maturity radar, gap analysis, and a 30-day action plan

The CGT operating model built in 2017 was never designed for today's multi-modality portfolio. Read the brief, then join the live conversation on June 11.

The question isn't just how the industry got here. It's what needs to change to support the next decade of cell and gene therapy innovation.

Back to the Future: Building CGT for a World That No Longer Exists